Research News for July 14, 2021
advertisement
- Immunogenicity of the novel glucagon analog dasiglucagon: Results of a dedicated immunogenicity trial in type 1 diabetes (HTML)
- 100 years of physiology, discrimination and wonder (HTML)
- Changes in Plasma and Urine Metabolites Associated with Empagliflozin in Patients with Type 1 Diabetes (HTML)
- Use of the Whole Country Insulin Consumption Data in Israel to Determine the Prevalence of Type 1 Diabetes in Children <5 Years of Age Before and During Rotavirus Vaccination (HTML)
- The enteroendocrine-osseous axis in patients with long-term type 1 diabetes mellitus (HTML)
- Serum urate and cardiovascular events in the DCCT/EDIC study (HTML)
- Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study (HTML)
- Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes (HTML)
- The low-expression variant of FABP4 is associated with cardiovascular disease in type 1 diabetes (HTML)
- The dark side of insulin: a primary autoantigen and instrument of self-destruction in type 1 diabetes (HTML)
- Evaluation of protocol amendments to the Environmental Determinants of Islet Autoimmunity (ENDIA) study during the COVID-19 pandemic (HTML)
